| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |